A detailed history of Becker Capital Management Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Becker Capital Management Inc holds 49,085 shares of BDX stock, worth $11.2 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
49,085
Previous 50,008 1.85%
Holding current value
$11.2 Million
Previous $11.7 Million 1.26%
% of portfolio
0.39%
Previous 0.4%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$221.47 - $242.41 $204,416 - $223,744
-923 Reduced 1.85%
49,085 $11.8 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $153,497 - $167,887
-682 Reduced 1.35%
50,008 $11.7 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $60,463 - $64,162
-259 Reduced 0.51%
50,690 $12.5 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $45,286 - $52,109
-195 Reduced 0.38%
50,949 $12.4 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $83,352 - $92,733
-327 Reduced 0.64%
51,144 $13.2 Million
Q2 2023

Aug 11, 2023

BUY
$238.39 - $265.32 $191,427 - $213,051
803 Added 1.58%
51,471 $13.6 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $256,586 - $289,693
-1,117 Reduced 2.16%
50,668 $12.5 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $41,475 - $48,812
-190 Reduced 0.37%
51,785 $13.2 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $28,015 - $145,062
-549 Reduced 1.05%
51,975 $11.6 Million
Q2 2022

Aug 04, 2022

SELL
$234.74 - $275.42 $96,243 - $112,922
-410 Reduced 0.77%
52,524 $12.9 Million
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $254,360 - $282,381
-1,044 Reduced 1.93%
52,934 $14.1 Million
Q4 2021

Feb 08, 2022

SELL
$230.08 - $250.94 $1.05 Million - $1.15 Million
-4,584 Reduced 7.83%
53,978 $13.6 Million
Q3 2021

Oct 14, 2021

SELL
$232.72 - $256.47 $56,085 - $61,809
-241 Reduced 0.41%
58,562 $14.4 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $164,948 - $180,497
709 Added 1.22%
58,803 $14.3 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $25,529 - $28,256
110 Added 0.19%
58,094 $14.1 Million
Q4 2020

Feb 10, 2021

SELL
$221.92 - $245.94 $155,565 - $172,403
-701 Reduced 1.19%
57,984 $14.5 Million
Q3 2020

Nov 09, 2020

SELL
$215.77 - $276.76 $355,373 - $455,823
-1,647 Reduced 2.73%
58,685 $13.7 Million
Q2 2020

Aug 11, 2020

SELL
$219.9 - $263.41 $1.31 Million - $1.57 Million
-5,973 Reduced 9.01%
60,332 $14.4 Million
Q1 2020

May 07, 2020

SELL
$195.69 - $279.01 $124,263 - $177,171
-635 Reduced 0.95%
66,305 $15.2 Million
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $470,062 - $530,438
-1,988 Reduced 2.88%
66,940 $18.2 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $982,270 - $1.09 Million
-4,260 Reduced 5.82%
68,928 $17.4 Million
Q2 2019

Aug 08, 2019

BUY
$217.4 - $246.08 $194,355 - $219,995
894 Added 1.24%
73,188 $18.4 Million
Q1 2019

May 08, 2019

SELL
$206.05 - $248.17 $668,014 - $804,567
-3,242 Reduced 4.29%
72,294 $18.1 Million
Q4 2018

Feb 04, 2019

SELL
$204.73 - $257.93 $585,118 - $737,163
-2,858 Reduced 3.65%
75,536 $17 Million
Q3 2018

Nov 05, 2018

SELL
$233.07 - $256.0 $229,573 - $252,160
-985 Reduced 1.24%
78,394 $20.5 Million
Q2 2018

Aug 03, 2018

SELL
$208.1 - $233.85 $508,388 - $571,295
-2,443 Reduced 2.99%
79,379 $19 Million
Q1 2018

May 07, 2018

SELL
$205.46 - $240.27 $1.17 Million - $1.37 Million
-5,688 Reduced 6.5%
81,822 $17.7 Million
Q4 2017

Feb 13, 2018

SELL
$189.0 - $222.64 $1.2 Million - $1.41 Million
-6,352 Reduced 6.77%
87,510 $18.7 Million
Q3 2017

Nov 02, 2017

SELL
$186.89 - $198.9 $180,535 - $192,137
-966 Reduced 1.02%
93,862 $18.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
94,828
94,828 $18.5 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.